CLF065 for Chronic Pouchitis

Summary

This clinical trial is to evaluate investigational compound CLF065 as a treatment for adult patients with chronic pouchitis. The goals are to establish the safety, feasibility and efficacy of weekly dosing of long acting CLF065 versus placebo.

Timeline

Start

2026-06-01

Primary completion

2027-03

Completion

2027-06

Outcome

Outcome not reported

Stopped: “Clinical Hold”

Drugs

Indications